#glp-1-receptor-agonists

[ follow ]
#obesity
more#obesity
fromwww.glasgowtimes.co.uk
1 month ago

Urgent Mounjaro and Ozempic warning for anyone planning a holiday

Travelers using weight-loss medications must declare them for insurance coverage to avoid financial risks abroad.
#weight-loss
Cancer
fromwww.theguardian.com
2 months ago

Weight-loss jabs could halve risk of obesity-related cancers, study finds

Weight-loss injections significantly reduce the risk of obesity-related cancers, suggesting a new approach to preventive medicine.
Cancer
fromwww.theguardian.com
2 months ago

Weight-loss jabs could halve risk of obesity-related cancers, study finds

Weight-loss injections significantly reduce the risk of obesity-related cancers, suggesting a new approach to preventive medicine.
more#weight-loss
#diabetes
fromwww.theguardian.com
1 month ago
Alternative medicine

Weight loss drugs linked to higher risk of eye damage in diabetic patients

GLP-1 RA weight loss drugs significantly increase the risk of age-related macular degeneration in diabetic patients.
Public health
fromScienceDaily
5 months ago

Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle

GLP-1 receptor agonists help lower blood sugar and aid weight loss by reducing fat mass more than muscle mass.
Public health
fromScienceDaily
5 months ago

Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle

GLP-1 receptor agonists help lower blood sugar and aid weight loss by reducing fat mass more than muscle mass.
more#diabetes
Alternative medicine
fromenglish.elpais.com
3 months ago

The Ozempic universe expands: These drugs also treat fatty liver disease

Ozempic drugs show promise in treating fatty liver disease, halting or reversing its progression, and may provide broader therapeutic effects beyond weight loss.
fromNew York Post
3 months ago

Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic

"The drug also lowered patients' blood sugar levels by 1.3% on average, while the overall efficacy of orforglipron in promoting weight loss and controlling diabetes has been met with enthusiasm."
Wearables
Mental health
fromPsychology Today
4 months ago

The Psychology of Addiction and Obesity: New Treatments

Addiction and obesity share neurological pathways, reinforcing compulsive behaviors.
GLP-1 receptor agonists may help regulate both appetite and addictive cravings.
Emerging compounds, such as MEAI, are being studied for its potential in addiction treatment.
A holistic approach combining therapy, medication, and new research offers hope.
US news
fromBoston.com
5 months ago

Could obesity drugs help with alcohol cravings? New study suggests potential

GLP-1 receptor agonists show potential in reducing alcohol cravings but safety for non-obese individuals remains uncertain.
[ Load more ]